UTI Testing Report That Helps Support Treatment Decisions
Enhanced PCR reporting with CLSI M100 guidelines to support clinical decision-making and antibiotic stewardship
This enhanced reporting is intended to supplement, not replace, routine laboratory reports and standard clinical protocols.
Healthcare providers should continue to follow established diagnostic and treatment guidelines.
Intelligent Reporting Solution
Phone:
CLIA #:
Director:
Patient Name:
MRN:
Accession:
Patient Number:
Birth:
Collection Date:
Provider:
Age:
Received Date:
Home Phone:
Gender:
Specimen Matrix:
UrineAccount:
E. coli
Low
Sulfonamides
Trimethoprim
Macrobid Comment
Sulfadiazine, Sulfamethizole, Sulfamethoxazole, Sulfasalazine. Sulfisoxazole
Primsol
The organism is carrying antibiotic resistance markers that
correlate with potential Macrobid (nitrofurantoin) resistance.
Ampicillin
Ampicillin-Sulbactam
Cefazolin
Ceftriaxone
Ciprofloxacin
Levofloxacin
Nitrofurantoin
Trimethoprim-sulfamethoxazole
Penicillin
Penicillin with beta-lactamase inhibitor
First-generation cephalosporin
Third-generation cephalosporin
Fluoroquinolone
Fluoroquinolone
Nitrofuran
Sulfonamide combination
Original Reported On:
Accession:
Patient:
Printed:
Lab Result for:
How does this benefit you?

.png)
Partner with Streamline Scientific to help shape the future of enhanced PCR reporting.
This enhanced reporting is intended to supplement, not replace, routine laboratory reports and standard clinical protocols. Healthcare providers should continue to follow established diagnostic and treatment guidelines.